Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research7/9/2026Positive
IQV
IQVIA Holdings IncNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$34.09B
P/E Ratio
25.34
EPS
$8.06
Beta
1.20
52W High
$247.05
52W Low
$154.50
50-Day MA
$177.56
200-Day MA
$195.61
Dividend Yield
—
Profit Margin
8.33%
Forward P/E
16.18
PEG Ratio
0.83
About IQVIA Holdings Inc
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Fundamentals
| Revenue (TTM) | $16.63B |
| Gross Profit (TTM) | $5.49B |
| EBITDA | $3.00B |
| Operating Margin | 13.60% |
| Return on Equity | 22.50% |
| Return on Assets | 5.13% |
| Revenue/Share (TTM) | $97.79 |
| Book Value | $37.27 |
| Price-to-Book | 5.55 |
| Price-to-Sales (TTM) | 2.05 |
| EV/Revenue | 2.917 |
| EV/EBITDA | 13.79 |
| Quarterly Earnings Growth (YoY) | 15.00% |
| Quarterly Revenue Growth (YoY) | 8.40% |
| Shares Outstanding | $166.90M |
| Float | $158.55M |
| % Insiders | 1.08% |
| % Institutions | 103.94% |
Historical Volatility
HV 10-Day
46.45%
HV 20-Day
43.55%
HV 30-Day
47.73%
HV 60-Day
46.39%
HV Rank
73.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($229.63 target)
3
Strong Buy16
Buy3
HoldLatest News
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter 2026 financial results before the market opens on Tuesday, July 28, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying.
Business Wire7/8/2026Neutral
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now
IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.
Zacks Investment Research7/3/2026Negative
StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertising
TORONTO--(BUSINESS WIRE)--StackAdapt (www.stackadapt.com), the leading AI advertising and orchestration platform, today announced a collaboration with IQVIA Digital to advance more relevant and compliant engagement with healthcare audiences. IQVIA Digital's integrated solutions enable marketers to quickly transform data-driven insights into meaningful, privacy-conscious activation across the healthcare ecosystem.Through this collaboration, StackAdapt's programmatic advertising capabilities are n.
Business Wire6/18/2026Neutral
The Healthcare M&A Wave
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
Forbes6/17/2026Neutral
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research6/17/2026Positive
Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More
Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.
24/7 Wall Street6/17/2026Neutral
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity
IQVIA Holdings gains from its vast healthcare data, AI-driven analytics & global IT infrastructure, supporting expansion and solid growth.
Zacks Investment Research6/15/2026Positive
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research6/15/2026Positive
Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies. The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The sessi.
Business Wire6/15/2026Neutral
More HEALTHCARE Stocks
Data last updated: 7/9/2026